Twist Bioscience Corp (TWST) stock
TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-K on Nov 16, 2026Score 13/30231% above fair value
$116.35+4.35 (+3.88%)
Close on Nov 18, 2026Market cap $7.30BP/E –Yield –
Twist Bioscience price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Twist Bioscience's price to sales ratio was 17.8× on Nov 11, 2026, against 5.2× a year earlier. Over the last 5 years it ranged from 3.3× to 28.9×, with a median of 8.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 17.8× | +12.7 |
| 2025 | Dec 31, 2025 | 5.1× | −3.6 |
| 2024 | Dec 31, 2024 | 8.7× | +0.1 |
| 2023 | Dec 29, 2023 | 8.7× | +2.0 |
| 2022 | Dec 30, 2022 | 6.6× | −22.3 |
| 2021 | Dec 31, 2021 | 28.9× | −41.7 |
| 2020 | Dec 31, 2020 | 70.7× | +58.0 |
| 2019 | Dec 31, 2019 | 12.7× | +9.8 |
| 2018 | Dec 31, 2018 | 2.9× | – |
See a number that looks wrong?